2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
NielsenIQ and TransUnion Collaborate to Enable Targeted Adve... (2024-01-22)
¿¹½º24, ´ë±¹¹Î µ¶¼­ 縰Áö ¡®¸ÅÀÏ 10ºÐ µ¶¼­ ½ÃÁð 3¡¯ ÁøÇà (2024-01-22)
Çö´ëÀÚµ¿Â÷, ¡®¹Ì·¡¸ðºô¸®Æ¼Çб³¡¯ ¸ðÁý (2023-11-12)
Á¦ÁÖµµ ÇÏ´Ã ¿¬´Þ ¸¶À» Ææ¼Ç ºÐ¾ç (2016-12-21)
'Àå·Ä¿ÕÈÄ' äºó, Á¤¸í°øÁÖ¿¡°Ô Èû º¸ÅÉ´Ù (2015-09-15)
µð¿Ã, °¶·¯¸®¾Æ ¹éÈ­Á¡¿¡¼­ °Ü¿ï Ä÷º¼Ç ÆË¾÷½ºÅä¾î ¿ÀÇ (2023-08-04)
¹è¿ì ¹®ÁöÀÎ, ¼­¿ï¿ìÀ¯Çùµ¿Á¶ÇÕ ¡®ÇÁ·çƼȨ¡¯ ±¤°í ¸ðµ¨ ¼±Á¤ (2024-08-30)
Following a year of elections held worldwide, Allianz launch... (2024-12-06)
¿Ü½Ä¹®È­ ¹ßÀü°ú °øÇå À§ÇÑ MOU ü°á (2024-01-27)
´ÜÃþ ±Ý¼Ó Ã˸ſ¡ °áÇÔ µµÀÔÇØ ¼ö¼Ò »ý»ê È¿À² Çâ»ó (2024-06-22)
¿ì¸®ëÞ, ÀüÀÚ¹«¿ª ¼Û±Ý ¼­ºñ½º °³¼±¡¦ ÀºÇà ¹æ¹® ¾È ÇØµµ µÈ´Ù (2024-07-21)
SW19, Á¤¼öÁ¤ ºê·£µå °ø½Ä ¸ðµ¨·Î ¼±Á¤ (2024-09-08)
Çõ½ÅÀûÀÎ ¹Ì¼ú ¼ö¾÷ÀÇ ÇöÀå ¡®¹Ì¼ú ¼ö¾÷ »õ·Î°íħ¡¯ (2024-08-17)
ForeverGone is Proven to Remove and Completely Destroy PFAS ... (2024-10-25)
GS25, µ¿¿ø¡¤´ë»ó°ú ¼ÕÀâ°í µµ½Ã¶ô °³¹ß (2024-08-26)
±¹³» Àα⠹öÆ©¹ö IP Ȱ¿ëÇÑ ¹Ì¿¬½Ã °ÔÀÓ Ãâ½Ã (2024-07-17)
KGÀ̴Ͻýº, Ä«µå À¯È¿¼º ÀÚµ¿ °ËÁõ ¼Ö·ç¼Ç ƯÇã±Ç (2024-06-27)
¾Ë·¹¸£±â Áúȯ, ȯÀÚ´ç ¿¬°£ 1800~6600À¯·Î Á÷Á¢ ºñ¿ë ¹ß»ý (2024-06-07)
IBK±â¾÷ÀºÇà-Á¶´Þû, Çõ½ÅÀû ±â¼ú±â¾÷ ±Û·Î¹ú ¼ºÀå Çù·Â (2023-10-02)
»ùÇ¥-³óÃÌÁøÈïû, ¡®¹Ù·Î¹Ì2¡¯·Î Á¦´ë·Î µÈ °íÃßÀå ¸À ±¸Çö (2023-10-31)
¹Ì½¦¸°ÀÌ º¹ÇÕ¼ÒÀç ¹× °æÇè Àü¹® ±â¾÷ÀÎ ÀÌÀ¯ (2024-07-15)
³×½ºÄ«Æä µ¹Ã¼±¸½ºÅä ¡®Áö´Ï¿ÀS ½¦¾î ¸ðÄ«¡¯ Ãâ½Ã (2023-08-30)
¾ËÆÄ¼¼´ëÀÇ »ýÁ¸ À§ÇÑ °æÁ¦ ±³À° ÇÁ·Î±×·¥ ¡®Å²´õ¿¡¼Â¡¯ (2024-08-13)
Supreme Court Sanctions Agreement for FTX DM Joint Official ... (2025-02-09)
'µ¶¹ÚÅõ¾î¡¯ ±è´ëÈñ, ±èÁØÈ£¿Í ²Ùµû ÇØº¯¼­ ³­Åõ±Ø? (2024-07-13)
       [ÀÌÀü][1]....[546][547][548][549][550][551][552][553][554]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..